Status:
UNKNOWN
Analysis of Extraperitoneal Rectal Neoplasms Between 3D Endorectal Ultrasonography and Magnification Chromoendoscopy
Lead Sponsor:
University of Sao Paulo
Conditions:
Rectal Cancer
Rectal Cancer Stage I
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
ERUS-3D and CMI demonstrated good diagnostic accuracy in parietal staging of rectal extraperitoneal neoplasms, however with greater efficiency of the endoscopic method. The association of studies can ...
Detailed Description
Larger lesions present less chance of deep parietal invasion. The methods show moderate agreement with each other for lesion size and distance from the anal verge and good agreement for the rectal wal...
Eligibility Criteria
Inclusion
- patients with diagnosis of mid or distal rectum neoplasms stage 1 -
Exclusion
- advanced rectal cancer (stage II, III or IV)
- \-
Key Trial Info
Start Date :
August 7 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 7 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04527939
Start Date
August 7 2020
End Date
August 7 2023
Last Update
August 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medicine School, Sao Paulo University
São Paulo, Brazil, 05403-900